Get the App

Back Stocks profile

Stock analysis tool for investors

Aarti Drugs Ltd.

NSE: AARTIDRUGS | BSE:524348

₹502.60 1.80 (0.36%) 1D

Pharmaceuticals & Biotechnology

Buy Sell
View detailed Technical chart

Open an Account with Bigul in 5 minutes

Performance

Today’s low

493.30

Today’s High

506.40

52W low

429.10

52W High

645.80

Open Price

502.20

Prev. Close

458.7000

Volume

102142.00

Value

51336569.20

Fundamentals

Market Cap Cr

4620.70

Price to Earnings

27.00

Price to Book Value

3.60

Dividend Yield

0.20

PE to Growth

8.80

Op Revenue TTM Cr

2528.58

Net Profit TTM Cr

171.42

Cash From Operating Activity Cr

358.92

Return on Equity %

13.38

EMA & SMA

Bullish Moving Averages

14

Bearish Moving Averages

2

5Day EMA

502.5

10Day EMA

500.5

12Day EMA

499.4

20Day EMA

495

26Day EMA

493.1

50Day EMA

492.5

100Day EMA

496.6

200Day EMA

495.8

5Day SMA

503.8

10Day SMA

500.8

20Day SMA

497.7

30Day SMA

481.2

50Day SMA

487.8

100Day SMA

499.9

150Day SMA

499.2

200Day SMA

517.1

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

03 May, 2024

41.3

Week

46

Month

37.5

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

500.78

PIVOT

First Resistance

508.27

Second Resistance

513.93

Third Resistance

521.42

First Support

495.12

Second Support

487.63

Third Support

481.97

Relative Strength Index

57.02

Money Flow Index

56.87

MACD

6.27

MACD Signal

5.52

Average True Range

13.5

Average Directional Index

21.45

Rate of Change (21)

9.88

Rate of Change (125)

7.06

Commodity Channel Index

29

Williams %R

-45.1

BETA

1 Month

0.33

3 Month

1.13

1 Year

0.45

3 Year

0.38

PRICE CHANGE ANALYSIS

↓ -0.31%

1 Week

Low

High

493.3

514.3

↑ 5.88%

1 Month

Low

High

475.2

519.15

↓ -1.33%

3 Months

Low

High

431.05

568

↑ 9.25%

6 Months

Low

High

431.05

568

↑ 9.3%

1 Year

Low

High

429.1

645.75

Indicator Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Graph
Total Qtr Revenue cr 560.64 539.89 578.28 592.29 697.34 626.50 624.92 551.44 642.10 594.83 511.59
Operating Expenses Qtr 490.47 478.47 512.12 519.73 607.89 556.55 554.65 496.47 557.38 502.53 441.56
Operating Profit Qtr 69.06 59.74 65.42 71.90 88.52 68.98 70.18 54.73 84.10 90.68 69.14
EBIDT Qtr Cr 70.17 61.42 66.16 72.56 89.45 69.95 70.27 54.97 84.72 92.30 70.03
Depreciation Qtr 12.34 11.80 11.78 11.75 11.68 11.87 11.92 11.83 11.88 11.95 11.81
Net Profit Qtr 36.14 31.62 34.58 39.54 53.17 36.71 36.58 26.35 53.00 55.85 40.61
Basic EPS Qtr 3.93 3.44 3.75 4.27 5.74 3.96 3.95 2.85 5.72 6.03 4.39
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total Revenue Annual 2271.09 2500.20 2255.95 1921.31 1635.98
Operating Expenses Annual Cr 2000.78 2215.57 1932.99 1513.62 1390.51
Operating Profit Annual 266.13 282.40 318.18 401.27 244.41
Operating Profit Margin Annual % 11.72 11.30 14.10 20.89 14.94
Total Expenses Annual Cr 2078.61 2295.39 2000.45 1583.83 1469.39
EBIDT Annual Cr 270.31 284.64 322.96 407.69 245.47
EBIDT Annual margin % 11.90 11.38 14.32 21.22 15.00
Depreciation 47.67 47.29 47.39 47.60 46.67
PAT Before ExtraOrdinary Items Annual Cr 141.88 152.81 195.00 257.71 135.67
Net Profit Annual 141.88 152.81 195.00 257.71 135.67
Basic EPS Annual 15.35 16.50 21.04 27.65 58.12
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total ShareHolders Funds Annual 1175.21 1114.30 972.17 859.61 621.79
Minority Interest Liability Annual Cr - - - - -
Total Non Current Liabilities Annual Cr 311.81 250.20 207.67 255.50 292.91
Total Current Liabilities Annual Cr 684.60 830.99 854.68 521.89 555.99
Total Capital Plus Liabilities Annual Cr 2171.62 2195.50 2034.52 1637.01 1470.70
Fixed Assets Annual 942.16 795.23 709.03 646.47 622.53
Total Non Current Assets Annual 990.60 845.96 761.33 676.88 645.33
Total Current Assets Annual 1181.02 1349.53 1273.19 960.13 825.36
Total Assets Annual 2171.62 2195.50 2034.52 1637.01 1470.70
Contingent Liabilities plus Commitments Annual Cr - 258.17 194.24 152.85 89.82
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Cash from Operating Activity Annual 337.10 162.28 39.90 154.08 196.15
Cash from Investing Activity Annual -187.09 -131.14 -125.36 -68.93 -29.35
Cash from Financing Annual Activity -148.81 -30.54 84.11 -85.28 -167.76
Net Cash Flow Annual - 0.61 -1.35 -0.13 -0.96
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Book Value Per Share Annual 127.82 120.33 104.99 92.23 266.86
ROE Annual % 12.07 13.71 20.05 29.98 21.82
ROCE Annual % 14.97 17.39 23.35 32.29 21.73
Total Debt to Total Equity Annual 0.40 0.48 0.53 0.34 0.53
EBDIT Annual Margin % 11.92 11.39 14.34 21.29 15.01
Indicator Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Graph
Total Qtr Revenue cr 621.07 607.61 642.23 661.71 743.28 664.97 687.77 622.22 697.23 641.46 579.70
Operating Expenses Qtr 534.18 535.80 565.10 577.03 648.87 593.31 613.45 554.82 608.27 544.80 505.88
Operating Profit Qtr 85.81 70.14 76.44 84.08 93.54 70.65 74.27 67.14 86.00 90.00 73.74
EBIDT Qtr Cr 86.89 71.81 77.13 84.68 94.41 71.66 74.32 67.40 88.96 96.66 73.82
Depreciation Qtr 13.58 12.66 12.61 12.60 12.50 12.62 12.66 12.54 12.55 12.60 12.48
Net Profit Qtr 47.31 36.67 39.59 47.85 56.09 36.68 38.75 34.79 55.32 58.28 42.58
Basic EPS Qtr 5.15 3.99 4.29 5.18 6.07 3.96 4.18 3.76 5.97 6.29 4.60
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total Revenue Annual 2532.61 2718.25 2499.96 2159.30 1807.57
Operating Expenses Annual Cr 2212.11 2410.45 2159.21 1717.67 1544.27
Operating Profit Annual 316.47 305.61 329.44 437.10 261.82
Operating Profit Margin Annual % 12.50 11.24 13.18 20.24 14.48
Total Expenses Annual Cr 2297.08 2494.07 2230.01 1790.52 1626.75
EBIDT Annual Cr 320.50 307.80 340.75 441.63 263.30
EBIDT Annual margin % 12.65 11.32 13.63 20.45 14.57
Depreciation 51.45 50.32 50.05 49.88 48.75
PAT Before ExtraOrdinary Items Annual Cr 171.59 166.36 205.00 280.40 141.40
Net Profit Annual 171.59 166.31 205.04 280.41 141.40
Basic EPS Annual 18.56 17.97 22.12 30.09 60.57
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total ShareHolders Funds Annual 1281.55 1192.43 1036.36 913.42 652.49
Minority Interest Liability Annual Cr 0.41 0.23 -0.06 -0.02 -0.00
Total Non Current Liabilities Annual Cr 354.86 295.75 231.60 257.25 299.31
Total Current Liabilities Annual Cr 795.54 932.98 940.06 595.36 624.70
Total Capital Plus Liabilities Annual Cr 2432.36 2421.40 2207.96 1766.01 1576.50
Fixed Assets Annual 1070.22 886.58 766.67 684.66 656.02
Total Non Current Assets Annual 1111.64 929.05 814.59 709.22 672.50
Total Current Assets Annual 1320.72 1492.35 1393.37 1056.80 904.00
Total Assets Annual 2432.36 2421.40 2207.96 1766.01 1576.50
Contingent Liabilities plus Commitments Annual Cr - 262.94 211.49 155.67 92.06
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Cash from Operating Activity Annual 358.92 134.20 69.64 154.85 250.74
Cash from Investing Activity Annual -223.65 -163.97 -148.86 -71.68 -33.21
Cash from Financing Annual Activity -136.03 16.54 92.03 -81.13 -215.41
Net Cash Flow Annual - -13.23 12.80 2.04 2.13
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Book Value Per Share Annual 139.43 128.80 111.91 98.00 280.04
ROE Annual % 13.38 13.94 19.78 30.69 21.67
ROCE Annual % 16.43 17.29 22.92 33.46 22.54
Total Debt to Total Equity Annual 0.44 0.51 0.52 0.33 0.52
EBDIT Annual Margin % 12.67 11.33 13.69 20.49 14.57
Name Holding Percent Holding Id Pledged % Locked %
Name Holding Percent Holding Id Pledged % Locked %
Prakash Moreshwar Patil 9.24 75061479 0 0
Harshit Manilal Savla 4.74 75061480 0 0
Rashesh Chandrakant Gogri 4.65 75061481 0 0
Priti Prakash Patil 4.4 75061482 0 0
Seema Harshit Savla 3.84 75061483 0 0
Hetal Gogri Gala 3.06 75061484 0 0
Chandrakant Vallabhaji Gogri 1.87 75061485 0 0
Jaya Chandrakant Gogri 1.71 75061486 0 0
Mirik Rajendra Gogri 1.31 75061487 0 0
Renil Rajendra Gogri 1.25 75061488 0 0
Adhish P. Patil 1.24 75061489 0 0
Bhoomi Harshit Savla 1.09 75061490 0 0
Vishwa Harshit Savla 1.03 75061491 0 0
Aashay Rashesh Gogri 0.96 75061492 0 0
Rajendra Vallabhaji Gogri 0.52 75061493 0 0
Gogri Finserv Pvt. Ltd. 3.8 75061510 0 0
Anushakti Enterprise Private Limited 2.62 75061511 0 0
Alchemie Finserv Pvt. Ltd. 2.21 75061512 0 0
Aashyav Business Trust (Alabhya Trusteeship Private Limited) 1.5 75061513 0 0
Tulip Family Trust (Gloire Trusteeship Services Private Limited) 1.01 75061514 0 0
Orchid Family Trust (Relacion Trusteeship Services Private Limited) 0.99 75061515 0 0
Paridhi Business Trust (Saswat Trusteeship Private Limited) 0.64 75061516 0 0
Safechem Enterprises Private Limited 0.61 75061517 0 0
Dilesh Roadlines Pvt Ltd 0.54 75061518 0 0
Name Holding Percent Holding Id
DSP Small Cap Fund 5.02 75061524
Name Holding Percent Holding Id
Nikhil Parimal Desai 1.12 75061540
HUF 0.69 75061532
Harit Pragji Shah 2.67 75061544
Jayshree Harit Shah 1.79 75061545
Ex-Date Dividend Amount Dividend Type Record Date Instrument Type
Feb 06, 2024 1 INTERIM Feb 06, 2024 Equity Share
Feb 08, 2023 1 INTERIM Feb 08, 2023 Equity Share
Feb 09, 2022 1 INTERIM Feb 10, 2022 Equity Share
Nov 03, 2020 2.5 INTERIM Nov 04, 2020 Equity Share
Feb 17, 2020 2 INTERIM Feb 18, 2020 Equity Share
Jul 26, 2019 1 FINAL - Equity Share
Aug 01, 2018 1 FINAL - Equity Share
Aug 09, 2017 1 FINAL - Equity Share
Mar 22, 2016 3 INTERIM Mar 24, 2016 Equity Share
Feb 12, 2016 1.5 INTERIM Feb 15, 2016 Equity Share
Nov 10, 2015 2.25 INTERIM Nov 14, 2015 Equity Share
Aug 05, 2015 3 FINAL - Equity Share
Feb 04, 2015 5 INTERIM Feb 05, 2015 Equity Share
Nov 19, 2014 5 INTERIM Nov 20, 2014 Equity Share
Jul 02, 2014 5.5 FINAL - Equity Share
Feb 05, 2014 4.5 INTERIM Feb 06, 2014 Equity Share
Nov 19, 2013 3 INTERIM Nov 20, 2013 Equity Share
Jul 24, 2013 4 FINAL - Equity Share
Feb 11, 2013 3 INTERIM Feb 12, 2013 Equity Share
Nov 05, 2012 3 INTERIM Nov 06, 2012 Equity Share
Aug 17, 2012 3 FINAL - Equity Share
Feb 06, 2012 2 INTERIM Feb 07, 2012 Equity Share
Jul 14, 2011 2.5 FINAL - Equity Share
Feb 07, 2011 2.5 INTERIM Feb 08, 2011 Equity Share
Aug 18, 2010 5 FINAL - Equity Share
Jul 23, 2009 3 FINAL - Equity Share
Aug 13, 2008 1.8 FINAL - Equity Share
Mar 20, 2007 1.2 INTERIM Mar 21, 2007 Equity Share
Jul 19, 2006 1.5 FINAL - Equity Share
Jul 27, 2005 1.6 FINAL - Equity Share
Nov 04, 2004 1.4 INTERIM Nov 06, 2004 Equity Share
Jun 25, 2004 1.8 FINAL - Equity Share
Nov 13, 2003 1.2 INTERIM Nov 15, 2003 Equity Share
Jul 25, 2003 1.5 FINAL - Equity Share
Jun 20, 2002 - FINAL - Equity Share
Oct 23, 2001 - INTERIM Nov 08, 2001 Equity Share
Jun 11, 2001 - FINAL - Equity Share
Ex-Date Split Ratio Record Date
Ex-Date Purpose Notes
May 03, 2024 Audited Results -
Jan 24, 2024 Quarterly Results & Interim Dividend -
Oct 19, 2023 Quarterly Results -
Jul 21, 2023 Quarterly Results & Buy Back -
Apr 29, 2023 Audited Results -
Jan 27, 2023 Quarterly Results & Interim Dividend -
Oct 20, 2022 Quarterly Results -
Jul 27, 2022 Quarterly Results -
May 09, 2022 Audited Results -
Jan 31, 2022 Audited Results & Interim Dividend -
Oct 27, 2021 Quarterly Results -
Jul 27, 2021 Quarterly Results -
May 15, 2021 Audited Results -
Mar 19, 2021 Buy Back of Shares -
Jan 25, 2021 Quarterly Results -
Oct 23, 2020 Audited Results -
Oct 20, 2020 Audited Results & Interim Dividend -
Aug 20, 2020 Bonus issue -
Jul 25, 2020 Quarterly Results -
May 15, 2020 Audited Results -
Feb 06, 2020 Quarterly Results & Interim Dividend -
Oct 23, 2019 Audited Results -
Jul 26, 2019 Quarterly Results -
May 15, 2019 Audited Results & Final Dividend -
Mar 15, 2019 Buy Back of Shares -
Feb 11, 2019 Quarterly Results -
Nov 02, 2018 Quarterly Results -
Aug 13, 2018 Quarterly Results -
May 16, 2018 Audited Results & Final Dividend -
Feb 13, 2018 Quarterly Results -
Jan 08, 2018 Buy Back of Shares -
Nov 13, 2017 Quarterly Results -
Aug 18, 2017 Quarterly Results -
May 23, 2017 Audited Results & Final Dividend -
Feb 08, 2017 Quarterly Results -
Nov 09, 2016 Quarterly Results -
Oct 17, 2016 Buy Back of Shares -
Aug 12, 2016 Quarterly Results -
May 05, 2016 Audited Results -
Mar 16, 2016 3rd Interim Dividend -
Feb 05, 2016 Quarterly Results & 2nd Interim Dividend -
Nov 06, 2015 Quarterly Results & Interim Dividend -
Jul 31, 2015 Quarterly Results -
May 20, 2015 Audited Results & Final Dividend -
Mar 26, 2015 Others To consider & approve the allotment of 121,08,550 Equity shares as Bonus issue in the proportion of 1 new equity share for every 1 (One) existing fully paid equity shares.
Jan 30, 2015 Quarterly Results & Interim Dividend Second Interim Dividend
Nov 14, 2014 Quarterly Results & Interim Dividend -
Aug 08, 2014 Quarterly Results -
Apr 30, 2014 Audited Results & Final Dividend -
Jan 31, 2014 Quarterly Results & 2nd Interim Dividend -
Nov 14, 2013 Quarterly Results & Interim Dividend -
Aug 02, 2013 Quarterly Results -
May 16, 2013 Audited Results & Final Dividend -
Feb 06, 2013 Quarterly Results & Interim Dividend -
Oct 31, 2012 Quarterly Results & Interim Dividend -
Aug 10, 2012 Quarterly Results -
Jul 09, 2012 Audited Results Inter alia, to reconsider, approve and take on record the Audited Financial Results for the year ended March 31, 2012, post amalgamation of Suyash Laboratories Ltd. with the Company.
May 25, 2012 Audited Results & Final Dividend -
Feb 09, 2012 Others The Board has consider the Sucession Plan post retirement of Shri. Chandrakant V Gogri as the Chairman of the Company w.e.f August 16, 2012 on his attaining the age of 66 years.
Feb 01, 2012 Quarterly Results & Interim Dividend -
Nov 11, 2011 Quarterly Results -
Jul 29, 2011 Quarterly Results -
May 25, 2011 Audited Results & Final Dividend -
Feb 02, 2011 Quarterly Results & Interim Dividend -
Oct 29, 2010 Quarterly Results -
Jul 30, 2010 Quarterly Results -
May 26, 2010 Audited Results & Dividend -
Jan 25, 2010 Quarterly Results -
Dec 20, 2009 Allotment of Equity Shares The Board has allotted 4,00,000 Equity Shares of Rs. 10/- each fully paid up against exercise of option of Conversion by the holders of Conv. Warrants issued by the Company on preferential basis.
Oct 30, 2009 Quarterly Results -
Jul 30, 2009 Quarterly Results -
May 20, 2009 Audited Results & Dividend -
Jan 29, 2009 Quarterly Results (Revised)
Oct 20, 2008 Quarterly Results -
Aug 06, 2008 To call an EGM & Others To consider: Allotment of one Equity share of Rs 10/- each & to determine "Relevant Date" for the purpose said issue price for the Preferential Issue of the warrants.
Jul 28, 2008 Quarterly Results -
May 13, 2008 Audited Results & Final Dividend -
Jan 28, 2008 Quarterly Results -
Oct 30, 2007 Quarterly Results -
Jul 30, 2007 Quarterly Results -
May 18, 2007 Audited Results & Final Dividend Has not recommended any final dividend.
Mar 12, 2007 Interim Dividend -
Jan 22, 2007 Quarterly Results -
Oct 19, 2006 Quarterly Results -
Jul 31, 2006 Quarterly Results -
May 10, 2006 Accounts & Dividend -
Jan 27, 2006 Quarterly Results -
Nov 08, 2005 Quarterly Results & Half Yearly Results -
Jul 29, 2005 Quarterly Results & Accounts (Revised)
May 05, 2005 Others Board has decided to acquire controlling stake in Suyash Laboratories Ltd (Suyash) thereby making it 51% subsidiary of the Company subject to necessary approvals from appropriate authority.
Apr 25, 2005 Accounts, Qtr Results & F. Dividend -
Apr 08, 2005 Allotment of Unsecured FCCB's Board has allotted 12750 Unsecured Foreign Currency Convertible Bonds (FCCBs) of US$ 1000 each aggregating to US$ 12,750,000 (US Dollar Twelve Million Seven Hundred Fifty Thousand Only).
Jan 21, 2005 Quarterly Results -
Dec 31, 2004 To issue securities like FCCB's Proposal to issue/offer securities like Foreign Currency Convertible Bonds (FCCB) and/or Equity Shares (through Depository Receipt Mechanism) and/or Fully Convertible Debentures.
Oct 29, 2004 Quarterly Results -
Jul 28, 2004 Accounts -
Apr 23, 2004 Accounts & Final Dividend -
Jan 21, 2004 Quarterly Results -
Oct 31, 2003 Interim Dividend & Quarterly Results (Revised)
Jul 21, 2003 Quarterly Results -
Apr 23, 2003 Final Dividend & Accounts -
Jan 20, 2003 Quarterly Results -
Oct 28, 2002 Accounts & Buy Back of Shares -
Jul 19, 2002 Quarterly Results -
May 10, 2002 Final Dividend -
Apr 17, 2002 Dividend & Quarterly Results -
Mar 09, 2002 Interim Dividend (Cancelled)
Jan 18, 2002 Quarterly Results -
Oct 31, 2001 Interim Dividend & Half Yearly Results -
Jul 18, 2001 Quarterly Results -
Apr 18, 2001 Accounts & Dividend Dividend announced on 11/04/2001
Jan 22, 2001 Quarterly Results -
Oct 18, 2000 Quarterly Results -
Apr 18, 2000 Accounts -
Mar 28, 2000 2nd Interim Dividend -
Jan 28, 2000 Quarterly Results -
Oct 27, 1999 Quarterly Results -
Jul 30, 1999 Quarterly Results -
Apr 29, 1999 Quarterly Results -
Jan 29, 1999 Quarterly Results -
Jan 22, 1999 Revised -
Jan 20, 1999 Quarterly Results -
Oct 30, 1998 Quarterly Results -
Jul 20, 1998 Quaterly Results -
May 05, 1998 Accounts & Dividend -
Nov 26, 1997 Half Yearly Results -
Ex-Date Bonus Ratio Record Date
Sep 30, 2020 3:1 2020-10-01
Mar 24, 2015 1:1 2015-03-25
Bigul
04 May 2024

AARTI DRUGS LTD. - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Intimation of Loss of share certificate.
Bigul
04 May 2024

AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Newspaper Publication of Financial Results.
Bigul
04 May 2024

AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Investor Presentation

 Investor Presentation for the Quater and Year ended March 31, 2024.
Bigul
03 May 2024

AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Press release on financial results for the quarter and year ended March 31, 2024
Bigul
03 May 2024

AARTI DRUGS LTD. - 524348 - Audited Standalone And Consolidated Financial Results For The Quarter And Year Ended March 31, 2024

 Financial Results for the quarter and year ended March 31, 2024
Bigul
03 May 2024

AARTI DRUGS LTD. - 524348 - Board Meeting Outcome for Audited Standalone And Consolidated Financial Results For The Quarter And Year Ended March 31, 2024 And Outcome Of The Meeting Of Board Of Directors Held On May 3, 2024.

 Audited Standalone and Consolidated Financial Results for the Quarter and Year ended March 31, 2024 and Outcome of the Meeting of Board of Directors held on May 3, 2024.
Bigul
30 Apr 2024

AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 This is with reference to our letter bearing Ref No. ADL/SE/2024-25/09 dated April 29, 2024, we would like to inform to you that the scheduled Quarterly Earning Conference Call for the Investors and Analysts on Monday, May 6, 2024 at 12:00 noon IST has been re-scheduled and will now take place at 11:00 A.M IST on the same day i.e. May 6, 2024.
Bigul
29 Apr 2024

AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 This is to inform you that Quarterly Earning Conference Call for the Investors and Analysts has been scheduled on Monday, May 6, 2024 at 12:00 noon IST to discuss the Company's financial performance for the Quarter ended March 31, 2024.
Bigul
26 Apr 2024

AARTI DRUGS LTD. - 524348 - Board Meeting Intimation for Financial Results For The Quarter And Year Ended March 31, 2024

 AARTI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/05/2024 ,inter alia, to consider and approve Audited Financial Results for the Quarter and year ended March 31, 2024.
Bigul
23 Apr 2024

AARTI DRUGS LTD. - 524348 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015

 We wish to inform you that US FDA has inspected the Formulation (Oncology) manufacturing facility of our Subsidiary (Pinnacle Life Science Private Limited) at Baddi, Himachal Pradesh
See all News

FAQs

The latest market price of Aarti Drugs Ltd. on NSE was Rs. 502.60 as of today.

The opening share price of Aarti Drugs Ltd. was Rs. 502.20 as of today.

The 52-week high share price of Aarti Drugs Ltd. was Rs. 645.80.

The 52 week low share price of Aarti Drugs Ltd. was Rs. 429.10.

Aarti Drugs Ltd. has a market cap of Rs. 4620.70 crore as of today. Please refer to the Fundamentals section for further details.

The PE ratio of Aarti Drugs Ltd. is 8.80. Please refer to the Fundamentals section for further details.

The operating revenue for Aarti Drugs Ltd. in the last FY was Rs.  2528.58 crore. Please refer to the Financials section for further details.

The Net Profit for Aarti Drugs Ltd. in the last FY was Rs. 171.42 crore. Please refer to the Financials section for further details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by Aarti Drugs Ltd. was on 2024-02-06 for Rs. 1 per share. According to today’s share price, the dividend yield of Aarti Drugs Ltd. stands at 0.20. Please refer to the Corporate Actions section for further details.

The latest bonus issue declared by Aarti Drugs Ltd. was as of 2020-09-30. The bonus ratio declared in this issue was 3:1. Please refer to the Corporate Actions section for further details.

Please find Corporate actions section for more details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Aarti Drugs Ltd..

Close

Let's Open Free Demat Account